Defense Lifts Moat Stocks As Tech Stumbles

Moat stocks / economic moat refers to companies that have a durable competitive advantage, such as a strong brand or cost advantage, which helps protect their profitability over time.

Key Risks:

Equity-market risk; concentration in technology shares; small-/mid-cap volatility; currency fluctuations; integration of sustainability risks may result in certain investments being avoided or divested, which could limit diversification; index methodology risk - this risk means that if the index changes its rules or which companies are included, it could impact how the fund performs. These factors can lead to significant losses, and past rallies may not be repeated. Complete information on all risks is available in the prospectus and in the KID/KIID, which can be accessed free of charge at vaneck.com. Past performance does not predict future returns.

Key Takeaways:

• Moat Index gained 2.13% in February, outperforming the S&P 500 by nearly 3 percentage points as defensive rotation favored its equal-weighted, valuation-conscious approach.
• Top contributors to Moat Index gains were Applied Materials, driven by strong earnings and confidence in AI infrastructure spending, and Bristol-Myers Squibb, which climbed on pipeline momentum and improving sentiment.
• SMID Moat Index rose 1.11% in February, trailing small- and mid-cap benchmarks as technology stock selection weighed on relative performance despite positive sector allocation.
• The SMID Moat Index was led by Hershey, thanks to easing cocoa cost headwinds and strong earnings, and Generac, boosted by data center backup power demand.

Index performance is not illustrative of fund performance.

U.S. equity markets experienced a notable divergence in February. An accelerating rotation out of mega-cap technology stocks and into more defensive and cyclical areas of the market drove starkly different outcomes across benchmarks. The S&P 500 declined 0.76% during the month, pulled lower by its heavy concentration in technology names, while the S&P 500 Equal Weight Index rose 3.55%, underscoring the breadth of participation outside of the largest constituents.

Concerns around artificial intelligence disruption of traditional software business models intensified early in the month, triggering a multi-day selloff in enterprise software names that extended a pattern of weakness that had been building in recent months. Leadership came from sectors positioned away from the AI disruption narrative, with utilities, energy, materials, and consumer staples all gaining between 8% and 10%.

The Morningstar Wide Moat Focus Index (the “Moat Index”) gained 2.13% in February, outperforming the S&P 500 by nearly 3 percentage points as the Index's equal-weighted, valuation-conscious approach proved well suited to the month's rotation away from mega-cap technology. Sector allocation was the overwhelming driver of relative performance, as the strategy's substantial overweights in consumer staples and industrials contributed meaningfully. The Moat Index's overweight to health care also provided a tailwind, while its underweight to information technology, which declined roughly 3.6%, was beneficial on a relative basis. Year-to-date through February, the Moat Index has gained 3.38%, leading the S&P 500's 0.68% return.

The Morningstar US Small-Mid Cap Moat Focus Index (the "SMID Moat Index") rose 1.11% in February but trailed both the S&P MidCap 400, which gained 4.12%, and the S&P SmallCap 600, which rose 2.17%. Small- and mid-cap stocks broadly outperformed large-caps during the month, consistent with the ongoing rotation into more cyclical and value-oriented areas of the market. Within the SMID Moat Index, stock selection was the primary headwind to relative performance this month, with weakness concentrated among information technology holdings. Sector allocation was modestly positive, with the strategy's overweight to materials and underweight to financials contributing favorably.

Defensive Leadership Lifts Moat Strategies in February

Source: Morningstar. Data as of 28/02/2026. Past performance is no guarantee of future results. Index performance is not representative of fund performance. It is not possible to invest directly in an index. Please see index definitions and other important disclosures at the end of this content. Fund performance current to the most recent month end is available by visiting vaneck.com.

Moat Index Highlights: Earnings Strength Overcomes Software Drag

In February, relative performance within the Moat Index was driven almost entirely by sector allocation, while stock selection was effectively neutral. Overweights in consumer staples and industrials were the primary contributors to relative performance versus the S&P 500, while the strategy's overweight to health care and underweight to information technology also proved beneficial during a month in which the cap-weighted benchmark was weighed down by its heavy concentration in technology names.

Applied Materials Inc. (AMAT) was the top contributor to Moat Index performance during the month, with shares rising approximately 16%. The company reported strong quarterly earnings results in mid-February and provided an impressive outlook for 2026, with management guiding for more than 20% growth in equipment sales driven by an accelerating AI infrastructure buildout cycle. Investor enthusiasm reflected growing confidence in a sustained, multi-year expansion in wafer fabrication equipment demand, as AI chip supply constraints continue to far outstrip available capacity. Morningstar views Applied Materials' position as the world's largest and most diversified supplier of wafer fabrication equipment as central to its wide economic moat, underpinned by intangible assets from its industry-leading research and development spending and steep switching costs from the complexity of its equipment and embedded customer relationships.

Bristol-Myers Squibb Co. (BMY) was the second-largest contributor, with shares gaining approximately 13%. The company reported full-year 2025 results in early February that demonstrated its ability to hold revenue roughly steady despite significant headwinds from generic competition for legacy oncology drugs. Growth in newer therapies, including Camzyos in cardiology, Reblozyl in hematology, and Breyanzi and Opdualag in oncology, reinforced the company's ability to diversify beyond maturing franchises. An active late-stage pipeline with numerous catalysts expected through the end of 2026 also supported investor sentiment, as the market increasingly looks toward Bristol-Myers' trajectory beyond the patent cliffs for Eliquis and Opdivo in 2028. Morningstar assigns Bristol-Myers a wide economic moat, supported by a broad lineup of patent-protected drugs, an entrenched salesforce, and economies of scale, and views shares as undervalued heading into a year filled with pipeline readouts.

Other notable contributors during the month included Clorox Co. (CLX), a household cleaning and consumer products company; United Parcel Service Inc. (UPS), a global package delivery and logistics provider; and The Hershey Co. (HSY), a confectionery and snack food company whose shares surged more than 22% following encouraging quarterly results and improving sentiment around easing cocoa cost headwinds.

Companies detracting the most from Moat Index performance in February were concentrated within technology and software, reflecting the broader market's intensifying concerns around AI disruption of traditional enterprise software business models. Workday Inc. (WDAY), a human capital management and financial software firm, was the largest detractor, with shares falling roughly 24%. Adobe Inc. (ADBE), a digital media and creative software company; Salesforce Inc. (CRM), a provider of enterprise cloud software; and Microsoft Corp. (MSFT) also weighed on results, as each was caught in the rolling selloff that impacted software names throughout the month. LPL Financial Holdings Inc. (LPLA), a brokerage platform supporting independent financial advisors, was the only non-software detractor among the bottom five.

Moat Index Top Contributors and Detractors - February 2026

Contributors

Detractors

Source: Morningstar. Past performance is no guarantee of future results. Index performance is not illustrative of fund performance. Not intended as a recommendation to buy or to sell any of the securities mentioned herein.

SMID Moat Index Highlights: Defensive Contributors Offset Tech Weakness

The SMID Moat Index posted a positive return in February, supported by contributions from consumer staples, health care and industrial holdings, though performance trailed small- and mid-cap benchmarks as stock selection within information technology weighed heavily. Sector allocation was modestly positive during the month, while the overall shortfall relative to benchmarks was attributable to company-specific weakness among several technology-oriented names.

The Hershey Co. (HSY) was the top contributor to SMID Moat Index performance, with shares rising more than 22%. Fourth-quarter results included 6% organic sales growth, and management's fiscal 2026 outlook called for more than 30% growth in adjusted earnings per share, signaling that the worst of the cocoa inflation headwinds may be easing. Morningstar views Hershey's dominant position in the U.S. confectionery aisle, where it holds more than one third of chocolate market share against minimal private-label competition, as the foundation of its wide economic moat, underpinned by strong intangible brand assets and an entrenched retail distribution network.

Generac Holdings Inc. (GNRC) was the second-largest contributor, with shares advancing approximately 34% during the month. The company reported fourth-quarter earnings that highlighted growing traction in the data center backup power market, with management guiding for 30% growth in commercial and industrial sales in 2026 as it executes against its growing backlog. Morningstar assigns Generac a narrow moat, supported by its dominant brand in home standby generators and cost advantages stemming from its unmatched scale in sales and distribution within the category.

Other notable contributors included Hasbro Inc. (HAS), a toy and entertainment company benefiting from its shift toward higher-margin digital gaming properties; Royalty Pharma PLC (RPRX), a buyer of biopharmaceutical royalties; and Zimmer Biomet Holdings Inc. (ZBH), a medical device company specializing in orthopedic implants.

Detractors from SMID Moat Index performance during February included several technology and software names, consistent with the pattern observed in the Moat Index. EPAM Systems Inc. (EPAM), a provider of digital platform engineering and software development services, was the largest detractor, with shares falling more than 32%. Zoom Communications Inc. (ZM), a provider of video communications and collaboration tools, declined roughly 20%, while Mattel Inc. (MAT), a toy manufacturer, fell approximately 19%. Workday Inc. (WDAY) and LPL Financial Holdings Inc. (LPLA) also detracted. The weakness among technology holdings reflected the same AI disruption concerns that pressured software names across the broader market, as investors reassessed the viability of traditional software business models in the face of rapidly advancing AI capabilities.

SMID Moat Index Top Contributors and Detractors - February 2026

Contributors

Detractors

Source: Morningstar. Past performance is no guarantee of future results. Index performance is not illustrative of fund performance. Not intended as a recommendation to buy or to sell any of the securities mentioned herein.

Choose Your Moat Strategy

VanEck’s suite of moat investing strategies is powered by Morningstar’s equity research team, which seeks quality companies trading at attractive valuations. The below ETFs offer access to moat companies across market segments:

VanEck Morningstar US Wide Moat UCITS ETF (MOTU): Seeks exposure to US companies considered by Morningstar’s equity analysts to have durable competitive advantages and appealing valuations.

VanEck Morningstar US ESG Wide Moat UCITS ETF (MOAT): Invests in potentially attractively priced, ESG-filtered US companies identified for sustainable competitive advantages by Morningstar. ESG Screens include exclusion of companies deriving revenues from Controversial Weapons, Civilian Firearms and Thermal Coal as defined by Sustainalytics as well as companies with higher levels of ESG-related risks according to Sustainalytics Estimates. Applying ESG Screens might also cause the investment universe to be limited in size, and the ETF may perform differently compared to non-screened portfolios. Investors should check all the characteristics of the fund before making any investment decision. Relevant disclosures can be found on fund page as well as under this link.

VanEck Morningstar US SMID Moat UCITS ETF (SMOT): Focuses on potentially undervalued US small- and mid-cap companies identified for their possible durable competitive advantages.

VanEck Morningstar Global Wide Moat UCITS ETF (GOAT): Targets high-quality global companies with wide economic moats and potential for long-term growth according to Morningstar.

The ETFs mentioned involve several risks. These include stock market risk (the value of your investment can go up or down), concentration risk (the ETFs may focus on certain sectors or companies and invest in fewer securities than those tracking plain benchmarks), and currency risk (returns can be affected by exchange rate changes).

Additional risks include valuation risk (companies that seem cheap may not perform well), smaller company risk (as smaller firms can be more volatile. Because the ETFs use equal weighting, each company has the same impact on performance, which may lead to different results compared to market-cap-weighted benchmarks. There’s also a chance the ETF doesn’t fully match its index performance (tracking error).

For further information on risks and other important information, please refer to the KID/KIID and the Prospectus of the funds, available at www.vaneck.com before investing.

To receive more Moat Investing insights, sign up to our newsletter.